Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9UJ71
UPID:
CLC4K_HUMAN
Alternative names:
Langerin
Alternative UPACC:
Q9UJ71
Background:
C-type lectin domain family 4 member K, also known as Langerin, is a calcium-dependent lectin with a specific affinity for mannose-binding. It plays a crucial role in the formation of Birbeck granules, essential for membrane dynamics and antigen presentation. Langerin's ability to bind to a variety of glycans, including keratan sulfate and beta-glucans, facilitates antigen uptake and processing, crucial for T cell activation. It serves as a primary receptor for several Candida and Saccharomyces species, as well as Malassezia furfur, and offers protection against HIV-1 by targeting the virus for degradation.
Therapeutic significance:
Given its pivotal role in immune response and protection against pathogens, including HIV-1, Langerin presents a promising target for therapeutic intervention. Understanding the role of Langerin could open doors to potential therapeutic strategies, particularly in enhancing immune defense mechanisms and developing treatments for infectious diseases.